메뉴 건너뛰기




Volumn 186, Issue 2-3, 2011, Pages 165-169

Smoking rates among schizophrenia patients in Japan

Author keywords

Epidemiology; Japan; Schizophrenia; Smoking

Indexed keywords

CARBON MONOXIDE;

EID: 79952359290     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2010.06.030     Document Type: Article
Times cited : (14)

References (38)
  • 1
    • 14844310395 scopus 로고    scopus 로고
    • Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions
    • Aguilar M.C., Gurpegui M., Diaz F.J., de Leon J. Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions. British Journal of Psychiatry 2005, 186:215-221.
    • (2005) British Journal of Psychiatry , vol.186 , pp. 215-221
    • Aguilar, M.C.1    Gurpegui, M.2    Diaz, F.J.3    de Leon, J.4
  • 3
    • 0038303560 scopus 로고    scopus 로고
    • Low prevalence of smoking in patients with autism spectrum disorders
    • Bejerot S., Ntylander L. Low prevalence of smoking in patients with autism spectrum disorders. Psychiatry Research 2003, 119:177-182.
    • (2003) Psychiatry Research , vol.119 , pp. 177-182
    • Bejerot, S.1    Ntylander, L.2
  • 4
    • 33645878629 scopus 로고    scopus 로고
    • Smoking is associated with schizophrenia, but not with mood disorders, within a population with low smoking rates: a matched case-control study in Bucaramanga, Colombia
    • Campo-Atrias A., Díaz-Martínez L.A., Rueda-Jaimes G.E., Rueda-Sánchez M., Farelo-Palacín D., Diaz F.J., de Leon J. Smoking is associated with schizophrenia, but not with mood disorders, within a population with low smoking rates: a matched case-control study in Bucaramanga, Colombia. Schizophrenia Research 2006, 83:269-276.
    • (2006) Schizophrenia Research , vol.83 , pp. 269-276
    • Campo-Atrias, A.1    Díaz-Martínez, L.A.2    Rueda-Jaimes, G.E.3    Rueda-Sánchez, M.4    Farelo-Palacín, D.5    Diaz, F.J.6    de Leon, J.7
  • 5
    • 20444463577 scopus 로고    scopus 로고
    • A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors
    • de Leon J., Diaz F.J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research 2005, 76:135-157.
    • (2005) Schizophrenia Research , vol.76 , pp. 135-157
    • de Leon, J.1    Diaz, F.J.2
  • 6
    • 0036736999 scopus 로고    scopus 로고
    • The association between high nicotine dependence and severe mental illness may be consistent across countries
    • de Leon J., Becoña E., Gurpegui M., Gonzalez-Pinto A., Diaz F.J. The association between high nicotine dependence and severe mental illness may be consistent across countries. Journal of Clinical Psychiatry 2002, 63:812-816.
    • (2002) Journal of Clinical Psychiatry , vol.63 , pp. 812-816
    • de Leon, J.1    Becoña, E.2    Gurpegui, M.3    Gonzalez-Pinto, A.4    Diaz, F.J.5
  • 7
    • 0036641259 scopus 로고    scopus 로고
    • Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital
    • de Leon J., Tracy J., McCann E., McGrory A., Diaz F.J. Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital. Schizophrenia Research 2002, 56:55-65.
    • (2002) Schizophrenia Research , vol.56 , pp. 55-65
    • de Leon, J.1    Tracy, J.2    McCann, E.3    McGrory, A.4    Diaz, F.J.5
  • 9
    • 45449108102 scopus 로고    scopus 로고
    • Smoking and schizophrenia: epidemiological and clinical features
    • Dervaux A., Laqueille X. Smoking and schizophrenia: epidemiological and clinical features. Encephale 2008, 34:299-305.
    • (2008) Encephale , vol.34 , pp. 299-305
    • Dervaux, A.1    Laqueille, X.2
  • 10
    • 0034958715 scopus 로고    scopus 로고
    • Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective
    • Desai H.D., Seabolt J., Jann M.W. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs 2001, 15:469-494.
    • (2001) CNS Drugs , vol.15 , pp. 469-494
    • Desai, H.D.1    Seabolt, J.2    Jann, M.W.3
  • 12
    • 3042671367 scopus 로고    scopus 로고
    • Stages of change in smokers with schizophrenia or schizoaffective disorders and in the general population
    • Etter M., Mohr S., Garin C., Etter F. Stages of change in smokers with schizophrenia or schizoaffective disorders and in the general population. Schizophrenia Bulletin 2004, 30:359-468.
    • (2004) Schizophrenia Bulletin , vol.30 , pp. 359-468
    • Etter, M.1    Mohr, S.2    Garin, C.3    Etter, F.4
  • 13
    • 0026800996 scopus 로고
    • Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects
    • Goff D.C., Henderson D.C., Amico E. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. American Journal of Psychiatry 1992, 149:1189-1194.
    • (1992) American Journal of Psychiatry , vol.149 , pp. 1189-1194
    • Goff, D.C.1    Henderson, D.C.2    Amico, E.3
  • 14
    • 49149124397 scopus 로고    scopus 로고
    • Longitudinal rates of smoking in a schizophrenia sample
    • Goldberg J.O., Van Exan J. Longitudinal rates of smoking in a schizophrenia sample. Tobacco Control 2008, 17:271-275.
    • (2008) Tobacco Control , vol.17 , pp. 271-275
    • Goldberg, J.O.1    Van Exan, J.2
  • 15
    • 0025923219 scopus 로고
    • The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire
    • Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction 1991, 86:1119-1127.
    • (1991) British Journal of Addiction , vol.86 , pp. 1119-1127
    • Heatherton, T.F.1    Kozlowski, L.T.2    Frecker, R.C.3    Fagerstrom, K.O.4
  • 18
    • 79952362687 scopus 로고    scopus 로고
    • Japan Tobacco Incorporated (JT)
    • Japan Tobacco Incorporated (JT) JT national survey of smoking rates http://www.jti.co.jp/News/2008/10/appendix20081023_01_01.html.
    • JT national survey of smoking rates
  • 19
    • 77953154081 scopus 로고    scopus 로고
    • Kousei-Toukei-Kyokai, Tokyo, in Japanese, Japanese Ministry of Health, Labour and Welfare
    • Japanese Ministry of Health, Labour and Welfare Patient Survey 2005 2007, Kousei-Toukei-Kyokai, Tokyo, in Japanese.
    • (2007) Patient Survey 2005
  • 20
    • 0347184804 scopus 로고    scopus 로고
    • Kousei-Toukei-Kyokai, Tokyo, in Japanese, Japanese Ministry of Health, Labour and Welfare
    • Japanese Ministry of Health, Labour and Welfare National Nutrition Survey 2005 2008, Kousei-Toukei-Kyokai, Tokyo, in Japanese.
    • (2008) National Nutrition Survey 2005
  • 21
    • 34547664796 scopus 로고    scopus 로고
    • How should DSM-V criteria for schizophrenia include cognitive impairment?
    • Keefe R.S., Fenton W.S. How should DSM-V criteria for schizophrenia include cognitive impairment?. Schizophrenia Bulletin 2007, 33:912-920.
    • (2007) Schizophrenia Bulletin , vol.33 , pp. 912-920
    • Keefe, R.S.1    Fenton, W.S.2
  • 22
    • 0032746548 scopus 로고    scopus 로고
    • Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland
    • Kelly C., McCreadie R.G. Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. American Journal of Psychiatry 1999, 156:1751-1757.
    • (1999) American Journal of Psychiatry , vol.156 , pp. 1751-1757
    • Kelly, C.1    McCreadie, R.G.2
  • 24
    • 0030017515 scopus 로고    scopus 로고
    • Interethnic differences in drug metabolism: influence of genetic and environmental factors on debrisoquine hydroxylation phenotype
    • Llerena A., Cobaleda J., Martínez C., Benítez J. Interethnic differences in drug metabolism: influence of genetic and environmental factors on debrisoquine hydroxylation phenotype. European Journal of Drug Metabolism Pharmacokinetics 1996, 21:129-138.
    • (1996) European Journal of Drug Metabolism Pharmacokinetics , vol.21 , pp. 129-138
    • Llerena, A.1    Cobaleda, J.2    Martínez, C.3    Benítez, J.4
  • 26
    • 1342343073 scopus 로고    scopus 로고
    • Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences
    • Margolese H.C., Malchy L., Negrete J.C., Tempier R., Gill K. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophrenia Research 2004, 67:157-166.
    • (2004) Schizophrenia Research , vol.67 , pp. 157-166
    • Margolese, H.C.1    Malchy, L.2    Negrete, J.C.3    Tempier, R.4    Gill, K.5
  • 29
    • 0034026474 scopus 로고    scopus 로고
    • Breath carbon monoxide as an indication of smoking habits
    • Middleton E.T., Morice A.H. Breath carbon monoxide as an indication of smoking habits. Chest 2000, 117:758-763.
    • (2000) Chest , vol.117 , pp. 758-763
    • Middleton, E.T.1    Morice, A.H.2
  • 32
    • 0347320662 scopus 로고    scopus 로고
    • Effects of socioeconomic indicators on coronary risk factors, self-rated health and psychological well-being among urban Japanese civil servants
    • Nishi N., Makino K., Fukuda H., Tatara K. Effects of socioeconomic indicators on coronary risk factors, self-rated health and psychological well-being among urban Japanese civil servants. Social Science & Medicine 2004, 58:1159-1170.
    • (2004) Social Science & Medicine , vol.58 , pp. 1159-1170
    • Nishi, N.1    Makino, K.2    Fukuda, H.3    Tatara, K.4
  • 33
    • 0027616581 scopus 로고
    • Cigarette smoking: effects on cognitive functions and drug-induced Parkinsonism in chronic schizophrenia
    • Sandyk R. Cigarette smoking: effects on cognitive functions and drug-induced Parkinsonism in chronic schizophrenia. The International Journal of Neuroscience 1993, 70:193-197.
    • (1993) The International Journal of Neuroscience , vol.70 , pp. 193-197
    • Sandyk, R.1
  • 37
    • 0033055995 scopus 로고    scopus 로고
    • Drug interactions with tobacco smoking. An update
    • Zevin S., Benowitz N.L. Drug interactions with tobacco smoking. An update. Clinical Pharmacokinetics 1999, 36:425-438.
    • (1999) Clinical Pharmacokinetics , vol.36 , pp. 425-438
    • Zevin, S.1    Benowitz, N.L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.